Advertisement
LifeSci Acquisition II Co... (LSAQ)
NASDAQ: LSAQ
· Real-Time Price · USD
9.01
-0.18 (-1.96%)
At close: Oct 07, 2021, 4:00 AM
Company Description
LifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry.
The company was founded in 2019 and is based in New York, New York.
LifeSci Acquisition II Corp.
| Country | United States |
| IPO Date | Nov 20, 2020 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Dr. Andrew Ian McDonald Ph.D. |
Advertisement
Contact Details
Address: 250 West 55th Street New York, New York United States | |
| Website | http://lifesciacquisition.com/spac-2/ |
Stock Details
| Ticker Symbol | LSAQ |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001819113 |
| CUSIP Number | |
| ISIN Number | US53229E1038 |
| Employer ID | 84-4278203 |
| SIC Code | 8731 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 25, 2024 | 15-12G | Filing |
| Mar 14, 2024 | 4 | Filing |
| Mar 14, 2024 | 4 | Filing |
| Mar 14, 2024 | 3/A | [Amend] Filing |
| Mar 14, 2024 | SC 13D/A | [Amend] Filing |
| Mar 13, 2024 | 4 | Filing |
| Mar 13, 2024 | 4 | Filing |
| Mar 13, 2024 | SC 13D/A | [Amend] Filing |
| Mar 12, 2024 | 4 | Filing |
| Mar 12, 2024 | 4 | Filing |